BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.83 EUR
2.91%
Market Closed
Updated:
Apr 26, 2024
Net Margin
BRAIN Biotech AG
BRAIN Biotech AG
-15.2%
Current
-16%
Average
4.6%
Industry
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=-15.2%
Net Income
/
-8.4m
Revenue
55.2m
Net Margin Across Competitors
Net Margin Comparison
BRAIN Biotech AG Competitors
BRAIN Biotech AG Competitors
| Country | DE |
| Market Cap | 61.8m EUR |
| Net Margin |
-15%
|
| Country | US |
| Market Cap | 78.4B USD |
| Net Margin |
11%
|
| Country | JP |
| Market Cap | 11.8T JPY |
| Net Margin |
22%
|
| Country | US |
| Market Cap | 63.2B USD |
| Net Margin |
9%
|
| Country | CH |
| Market Cap | 42.3B CHF |
| Net Margin |
9%
|
| Country | CH |
| Market Cap | 36.5B CHF |
| Net Margin |
13%
|
| Country | CN |
| Market Cap | 272.3B CNY |
| Net Margin |
10%
|
| Country | IN |
| Market Cap | 2.7T INR |
| Net Margin |
15%
|
| Country | US |
| Market Cap | 31.8B USD |
| Net Margin |
4%
|
| Country | US |
| Market Cap | 30.7B USD |
| Net Margin |
8%
|
| Country | CH |
| Market Cap | 27.7B EUR |
| Net Margin |
20%
|
Profitability Report
View the profitability report to see the full profitability analysis for BRAIN Biotech AG.
See Also
Discover More
What is Net Margin?
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin
=-15.2%
Net Income
/
-8.4m
Revenue
55.2m
What is the Net Margin of BRAIN Biotech AG?
Based on BRAIN Biotech AG's most recent financial statements, the company has Net Margin of -15.2%.
You don't have any saved screeners yet
